Propanc Biopharma (PPCB) Other Operating Expenses (2012 - 2019)
Propanc Biopharma (PPCB) posted quarterly Other Operating Expenses of $6287.0 for Q2 2019, down 7.37% year-over-year from $6787.0 in Q2 2018, and down 13.26% quarter-over-quarter from $7248.0 in Q1 2019.
Propanc Biopharma (PPCB) Other Operating Expenses (2012 - 2019) Analysis & Trends
Propanc Biopharma (PPCB) has reported Other Operating Expenses for 8 consecutive years, with $6287.0 the latest figure, recorded in Q2 2019.
- In Q2 2019, Other Operating Expenses fell 7.37% year-over-year to $6287.0; the TTM figure through Mar 2020 stood at $6287.0 (down 77.99% YoY), while the FY2018 annual figure was $30521.0, up 5.27% from the prior year.
- Other Operating Expenses eased to $6287.0 in Q2 2019 per PPCB's latest filing, from $7248.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $9488.0 in Q2 2016 and bottomed at -$3991.0 in Q2 2015.
- Historically, Other Operating Expenses has averaged $6138.9 across 5 years, with a median of $6771.0 in 2017.
- Annual changes were most pronounced in 2015 — Other Operating Expenses slumped 242.59% — and 2016, when it soared 337.73%.
- Propanc Biopharma's Other Operating Expenses stood at $4889.0 in 2015, then climbed by 22.54% to $5991.0 in 2016, then increased by 15.16% to $6899.0 in 2017, then fell by 6.52% to $6449.0 in 2018, then slipped by 2.51% to $6287.0 in 2019.
- Business Quant data shows PPCB's Other Operating Expenses at $6287.0 in Q2 2019, $7248.0 in Q1 2019, and $6449.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 6,287.00 |
| Mar 31, 2019 | 7,248.00 |
| Dec 31, 2018 | 6,449.00 |
| Sep 30, 2018 | 8,078.00 |
| Jun 30, 2018 | 6,787.00 |
| Mar 31, 2018 | 8,005.00 |
| Dec 31, 2017 | 6,899.00 |
| Sep 30, 2017 | 8,830.00 |
| Jun 30, 2017 | 6,755.00 |
| Mar 31, 2017 | 7,649.00 |
| Dec 31, 2016 | 5,991.00 |
| Sep 30, 2016 | 8,597.00 |
| Jun 30, 2016 | 9,488.00 |
| Mar 31, 2016 | 5,235.00 |
| Dec 31, 2015 | 4,889.00 |
| Sep 30, 2015 | 4,938.00 |
| Jun 30, 2015 | -3,991.00 |
| Mar 31, 2015 | 2,366.00 |
| Dec 31, 2014 | 2,567.00 |
| Sep 30, 2014 | 2,777.00 |